BioAtla hails CAB patent to increase antibody potency
BioAtla has received a broad patent covering conditionally active biologics (CABs) and says this antibody platform could shake up the development of this new class of therapeutics.
Archives for May 29, 2014
Australian biopharma calls for $1bn extra investment
The biotechnology and pharmaceutical bodies AusBiotech and Medicines Australia have asked the Australian Minister for Industry to invest in biopharma R&D and secure patents.
Michigan House introduces bill condoning biosimilar substitution
Michigan is the latest state to see a biosimilars bill come before its legislature as states pre-emptively grapple with how to deal with an expected influx of biosimilars.
Pall up on downstream as ATMI boosts sales but cuts margin
Pall says the acquisition of ATMI helped grow biopharmaceuticals sales 13% year-over-year, but negatively impacted gross margin for the third quarter.
SAFC expands continuous flow capacity in Wisconsin
SAFC, the custom manufacturing services business of Sigma-Aldrich, has installed a new commercial-scale continuous flow reactor at its Sheboygan, Wisconsin, facility with capacity to produce up to 150 kg of product per day.